Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
October 22, 2024 06:59 ET
|
Generation Bio Co.
New non-human primate data show highly selective in vivo delivery of mRNA to T cells with a cell-targeted lipid nanoparticle (ctLNP) CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Generation...
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference
September 12, 2024 16:05 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Second Quarter 2024 Financial Results
August 07, 2024 16:05 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
August 06, 2024 06:59 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
June 14, 2024 06:59 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
May 13, 2024 16:05 ET
|
Generation Bio Co.
- Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP) - ASGCT poster presentations described...
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
May 09, 2024 06:59 ET
|
Generation Bio Co.
Data presented show immune-quiet DNA (iqDNA) is a partially single-stranded DNA cargo that maintains expression while evading innate immune sensorsRapid enzymatic synthesis continues to improve iqDNA...
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
April 22, 2024 17:31 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today...
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024 06:59 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases,...
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024 16:20 ET
|
Generation Bio Co.
- Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia - Development of breakthrough...